Your browser doesn't support javascript.
loading
PTEN Regulates PI(3,4)P2 Signaling Downstream of Class I PI3K.
Malek, Mouhannad; Kielkowska, Anna; Chessa, Tamara; Anderson, Karen E; Barneda, David; Pir, Pinar; Nakanishi, Hiroki; Eguchi, Satoshi; Koizumi, Atsushi; Sasaki, Junko; Juvin, Véronique; Kiselev, Vladimir Y; Niewczas, Izabella; Gray, Alexander; Valayer, Alexandre; Spensberger, Dominik; Imbert, Marine; Felisbino, Sergio; Habuchi, Tomonori; Beinke, Soren; Cosulich, Sabina; Le Novère, Nicolas; Sasaki, Takehiko; Clark, Jonathan; Hawkins, Phillip T; Stephens, Len R.
Afiliação
  • Malek M; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Kielkowska A; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Chessa T; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Anderson KE; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Barneda D; Signalling Programme, Babraham Institute, Cambridge, UK; AstraZeneca R&D Cambridge, CRUK Cambridge Institute, Cambridge, UK.
  • Pir P; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Nakanishi H; Department of Medical Biology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Japan.
  • Eguchi S; Department of Medical Biology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Japan.
  • Koizumi A; Department of Urology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Japan.
  • Sasaki J; Department of Medical Biology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Japan.
  • Juvin V; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Kiselev VY; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Niewczas I; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Gray A; School of Life Sciences, University of Dundee, Dow St., Dundee, UK.
  • Valayer A; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Spensberger D; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Imbert M; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Felisbino S; Department of Morphology, Institute of Biosciences of Botucatu, Sao Paulo State University - UNESP, Botucatu, Sao Paulo, Brazil.
  • Habuchi T; Department of Urology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Japan.
  • Beinke S; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UK.
  • Cosulich S; AstraZeneca R&D Cambridge, CRUK Cambridge Institute, Cambridge, UK.
  • Le Novère N; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Sasaki T; Department of Medical Biology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Japan.
  • Clark J; Signalling Programme, Babraham Institute, Cambridge, UK.
  • Hawkins PT; Signalling Programme, Babraham Institute, Cambridge, UK. Electronic address: phillip.hawkins@babraham.ac.uk.
  • Stephens LR; Signalling Programme, Babraham Institute, Cambridge, UK. Electronic address: len.stephens@babraham.ac.uk.
Mol Cell ; 68(3): 566-580.e10, 2017 Nov 02.
Article em En | MEDLINE | ID: mdl-29056325

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfatidilinositóis / Neoplasias da Próstata / Neoplasias da Mama / Sistemas do Segundo Mensageiro / PTEN Fosfo-Hidrolase / Classe I de Fosfatidilinositol 3-Quinases Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Mol Cell Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfatidilinositóis / Neoplasias da Próstata / Neoplasias da Mama / Sistemas do Segundo Mensageiro / PTEN Fosfo-Hidrolase / Classe I de Fosfatidilinositol 3-Quinases Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Mol Cell Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido